BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33850787)

  • 1. Narrative review of prostate cancer grading systems: will the Gleason scores be replaced by the Grade Groups?
    Montironi R; Cheng L; Cimadamore A; Mazzucchelli R; Scarpelli M; Santoni M; Massari F; Lopez-Beltran A
    Transl Androl Urol; 2021 Mar; 10(3):1530-1540. PubMed ID: 33850787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.
    Srigley JR; Delahunt B; Samaratunga H; Billis A; Cheng L; Clouston D; Evans A; Furusato B; Kench J; Leite K; MacLennan G; Moch H; Pan CC; Rioux-Leclercq N; Ro J; Shanks J; Shen S; Tsuzuki T; Varma M; Wheeler T; Yaxley J; Egevad L
    Pathology; 2019 Aug; 51(5):463-473. PubMed ID: 31279442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
    Epstein JI; Amin MB; Reuter VE; Humphrey PA
    Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
    Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
    Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer.
    Samaratunga H; Delahunt B; Yaxley J; Srigley JR; Egevad L
    Scand J Urol; 2016 Oct; 50(5):325-9. PubMed ID: 27415753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading.
    Egevad L; Delahunt B; Srigley JR; Samaratunga H
    APMIS; 2016 Jun; 124(6):433-5. PubMed ID: 27150257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups.
    Offermann A; Hohensteiner S; Kuempers C; Ribbat-Idel J; Schneider F; Becker F; Hupe MC; Duensing S; Merseburger AS; Kirfel J; Reischl M; Lubczyk V; Kuefer R; Perner S
    Front Med (Lausanne); 2017; 4():157. PubMed ID: 29034236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer: from Gleason scoring to prognostic grade grouping.
    Montironi R; Santoni M; Mazzucchelli R; Burattini L; Berardi R; Galosi AB; Cheng L; Lopez-Beltran A; Briganti A; Montorsi F; Scarpelli M
    Expert Rev Anticancer Ther; 2016; 16(4):433-40. PubMed ID: 27008205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.
    Epstein JI; Amin MB; Fine SW; Algaba F; Aron M; Baydar DE; Beltran AL; Brimo F; Cheville JC; Colecchia M; Comperat E; da Cunha IW; Delprado W; DeMarzo AM; Giannico GA; Gordetsky JB; Guo CC; Hansel DE; Hirsch MS; Huang J; Humphrey PA; Jimenez RE; Khani F; Kong Q; Kryvenko ON; Kunju LP; Lal P; Latour M; Lotan T; Maclean F; Magi-Galluzzi C; Mehra R; Menon S; Miyamoto H; Montironi R; Netto GJ; Nguyen JK; Osunkoya AO; Parwani A; Robinson BD; Rubin MA; Shah RB; So JS; Takahashi H; Tavora F; Tretiakova MS; True L; Wobker SE; Yang XJ; Zhou M; Zynger DL; Trpkov K
    Arch Pathol Lab Med; 2021 Apr; 145(4):461-493. PubMed ID: 32589068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Utility of the Gleason Grading System Revisions and Histopathological Factors Beyond Gleason Grade.
    Zelic R; Giunchi F; Fridfeldt J; Carlsson J; Davidsson S; Lianas L; Mascia C; Zugna D; Molinaro L; Vincent PH; Zanetti G; Andrén O; Richiardi L; Akre O; Fiorentino M; Pettersson A
    Clin Epidemiol; 2022; 14():59-70. PubMed ID: 35082531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary Gleason grading and novel Grade Groups in clinical practice.
    Magi-Galluzzi C; Montironi R; Epstein JI
    Curr Opin Urol; 2016 Sep; 26(5):488-92. PubMed ID: 27308734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraductal carcinoma of the prostate (IDC-P) lowers apparent diffusion coefficient (ADC) values among intermediate risk prostate cancers.
    Currin S; Flood TA; Krishna S; Ansari A; McInnes MDF; Schieda N
    J Magn Reson Imaging; 2019 Jul; 50(1):279-287. PubMed ID: 30585372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma.
    Montironi R; Cimadamore A; Gasparrini S; Mazzucchelli R; Santoni M; Massari F; Cheng L; Lopez-Beltran A; Scarpelli M
    Expert Rev Anticancer Ther; 2018 Jul; 18(7):685-693. PubMed ID: 29699428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.
    Roobol MJ; Verbeek JFM; van der Kwast T; Kümmerlin IP; Kweldam CF; van Leenders GJLH
    Eur Urol; 2017 Jul; 72(1):45-51. PubMed ID: 28162815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long-term follow-up.
    Grogan J; Gupta R; Mahon KL; Stricker PD; Haynes AM; Delprado W; Turner J; Horvath LG; Kench JG
    BJU Int; 2017 Nov; 120(5):651-658. PubMed ID: 28371244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in prostate cancer pathology: Gleason grading and beyond.
    Shah RB; Zhou M
    Pathol Int; 2016 May; 66(5):260-72. PubMed ID: 26991008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of the International Society of Urological Pathology modified Gleason grading system.
    Egevad L; Mazzucchelli R; Montironi R
    Arch Pathol Lab Med; 2012 Apr; 136(4):426-34. PubMed ID: 22458905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy.
    Choy B; Pearce SM; Anderson BB; Shalhav AL; Zagaja G; Eggener SE; Paner GP
    Am J Surg Pathol; 2016 Oct; 40(10):1400-6. PubMed ID: 27379821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading - a matched-pair analysis.
    Berg KD; Thomsen FB; Nerstrøm C; Røder MA; Iversen P; Toft BG; Vainer B; Brasso K
    BJU Int; 2016 Jun; 117(6):883-9. PubMed ID: 26823232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.